Case ReportPubMed ID: 18297948·2008

Case Series: BPC-157 in Non-Healing Pressure Ulcers

Sikiric P, Tkalcevic G, Zenko A, et al.

Advances in Skin and Wound Care, 2008 · n = 4

Key finding

All 4 patients showed ≥50% ulcer area reduction within 6 weeks; 3 patients achieved complete closure by week 12 with improved epithelialization.

Summary

Case series of 4 patients with stage IV pressure ulcers showing significant acceleration of healing with local and systemic BPC-157 application.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

BPC-157L2

A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.

More research on BPC-157

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Sports Health · 2025 · Review

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study

Alternative Therapies in Health and Medicine · 2025 · Human Pilot

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity

Pharmaceuticals · 2024 · Review

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

Frontiers in Pharmacology · 2021 · Review

Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway

Scientific Reports · 2020 · Animal Study